Rare Disease Diagnostics
Genetic and molecular diagnosis of rare conditions
CommercialInnovating
Key Facts
Indication
Genetic and molecular diagnosis of rare conditions
Phase
Commercial
Status
Innovating
Company
About Synlab
SYNLAB is a fundamental part of national healthcare systems, providing actionable diagnostic information for healthy lives and well-being for all. With €2.62 billion in revenue in 2024 and over 24,000 employees including 2,000+ medical experts, the company leverages its extensive European footprint and scientific expertise to deliver reliable, high-quality diagnostics. SYNLAB's mission focuses on leadership through excellence in service, driving scientific innovation, and maintaining a value-based approach centered on passion, accountability, and customer centricity.
View full company profile